DRDO's anti-Covid drug 2-DG
will reduce oxygen dependency:
Union Health Minister Dr Harsh Vardhan on Monday said that
the recovery time from COVID-19 infection and oxygen
dependency will be reduced by anti-COVID drug 2-deoxy-D-
glucose (2-DG) developed by the Defence Research and
Development Organisation (DRDO).
While speaking at the release ceremony of the first batch of the
Covid 2-DG drug, Vardhan said, "With the support of DRDO and
in the leadership of Union Defence Minister Rajnath Singh, this
(anti-COVID drug 2DG) may be our first indigenous research-
based outcome to fight against COVID-19. It will reduce recovery
time and oxygen dependency."
"I hope that this drug will serve the world and not just India in the
fight against COVID-19 in the coming days," he further said.
"We have been combating COVID-19 for the past year and our
scientists have developed the vaccine and made it available to the
public. I thank and congratulate DRDO and its scientists. We have
seen that under Prime Minister Modi's leadership DRDO has
played an important role in the fight against COVID-19," he added.